GlassScriptPhysician profile
Robert J Goldman
NPI 1790808509
$579.96
in general payments reported to CMS, 2019-2025
7 companies · $24.39 in 2025
The $24.39 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.42 · 2023: $99.71 · 2024: $431 · 2025: $24.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $361.96 | 2022-2024 | Collagenase Santyl, Oasis, Grafix |
| Urgo Medical North America, LLC | $66.50 | 2023-2024 | Urgok2, Urgoclean Ag, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Solventum Corporation | $52.80 | 2024 | Activ.A.C., Promogran Prisma |
| Hydrofera LLC | $26.47 | 2023 | Hydrofera Blue |
| Kerecis Limited | $25.80 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Hartmann USA, INC. | $24.39 | 2025 | Zetuvit Plus 10x10 P10 |
| Integra Lifesciences Corporation | $22.04 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Goldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.